[Skip to Content]
[Skip to Content Landing]
September 4, 1972

Injectable Fluorouracil

JAMA. 1972;221(10):1158. doi:10.1001/jama.1972.03200230044011

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


In the ORIGINAL CONTRIBUTION, "Carcinoembryonic Antigen (CEA) in Colonic Cancer: Use in Preoperative and Postoperative Diagnosis and Prognosis," by Phani Dhar, MD; Terrence Moore, MD; Norman Zamcheck, MD; and Herbert Z. Kupchik, MD, published in the July 3 issue (221:31-35, 1972), the trade names Efudex and Fluoroplex were incorrectly given for fluorouracil. These trade names are for topically applied forms of fluorouracil, whereas in the communication, the injectable form was referred to. The injectable form is marketed by Hoffmann-La Roche under its non-proprietary name, fluorouracil.